The Discovery
The Search Begins
A scientist dreams of talking to skin cells
Key moment
Karl discovered that attaching a 16-carbon fatty acid chain to a peptide could multiply skin penetration by five to six times
Karl Lintner was not born into the peptide world. He grew up in Vienna, Austria, earning a chemical engineering degree and then a PhD in biochemistry from Vienna University. In 1973, he left Austria for France's Nuclear Research Center in Saclay, a place where scientists unlocked the secrets of tiny molecules. For ten years, he published papers about biological peptides, earning respect as a careful thinker. But Karl had a bigger dream: could these tiny peptides teach skin to heal itself? He believed that if you could make peptides stick to skin better, they could send stronger messages to skin cells below. Most scientists thought he was chasing a dream. Peptides in nature were water-loving, but skin's outer layer was fatty and water-hating. How could water-loving messages get through? Karl saw the answer while studying how other scientists had solved this problem. They had attached fatty acid chains to molecules to help them cross the skin barrier. If this worked for other compounds, why not peptides?
The Breakthrough
The Great Creation
Building a messenger that skin actually hears
Key moment
The first successful human studies showed 45% reduction in wrinkle depth in just eight weeks
In 1995, Karl Lintner joined a Spanish company called Sederma in Barcelona. This company made active ingredients for skincare. Karl brought his dream with him: create a peptide that talks to skin cells about making collagen. He teamed up with Claire Mas-Chamberlin, an expert at running careful tests on human skin. Together, they looked at the amino acid chain that naturally appears in damaged collagen. They identified five amino acids that skin cells recognize: lysine, threonine, threonine, lysine, and serine. Scientists abbreviated this as KTTKS. But here was the clever part: Karl attached a 16-carbon palmitic acid chain to the beginning of KTTKS. This created Matrixyl. The fatty chain was like giving the peptide a passport to enter skin. The five amino acids were like a message that said, 'Hey, make more collagen!' When they tested Matrixyl on human skin samples in the lab, the results shocked them. Fibroblasts—the cells that make collagen—woke up. They started producing collagen faster than normal. The messenger worked.
The Trials
The Proof
Showing the world that wrinkles can lose
Key moment
Scientific studies published in peer-reviewed journals proved Matrixyl's effectiveness, establishing it as the gold standard cosmetic peptide
When Matrixyl launched in 2000, many people were skeptical. Could a tiny synthetic peptide really fight wrinkles? But Sederma was smart. They did not just sell a product. They published scientific studies in real journals. Claire and her team measured skin changes carefully. They used special cameras that could see wrinkles at the level of millimeters. Over eight to twelve weeks, women using Matrixyl showed clear results. Wrinkles became shallower. The texture of skin improved. Collagen levels in the deep skin layer actually increased, measured by taking tiny skin samples and looking under microscopes. These were not small changes. Wrinkle surface area dropped by 45 to 68 percent depending on the study. Other companies noticed. Skincare brands began asking Sederma for supplies of Matrixyl. By 2005, the ingredient had become the most requested anti-wrinkle peptide in the world. Karl and Claire's dream was not just science anymore. It was in millions of bathroom cabinets. The skeptics had become believers.
The Crisis
The Recognition
A lifetime of work finally honored
Key moment
Karl Lintner awarded the Lifetime Achievement Award by in-cosmetics in Paris for pioneering cosmetic peptides
By 2006, something important happened. Sederma officially renamed their peptide from Palmitoyl Pentapeptide-3 to Palmitoyl Pentapeptide-4 to reflect new research and improved naming standards. Karl and Claire continued their work, publishing more studies with different populations. They tested Matrixyl on different skin types and ages. Everywhere, the results held up. The peptide worked. Scientists around the world started studying it. Universities ran their own tests. Independent researchers confirmed the findings. Matrixyl became the peptide that other peptides were compared against. It set the standard. Then on April 16, 2013, something special happened. The in-cosmetics conference in Paris held their annual awards. They gave Karl Lintner the Lifetime Achievement Award. In front of hundreds of scientists and industry leaders, they honored him as the father of Matrixyl and the pioneer of cosmetic peptides. Karl was in his seventies by then, but he still worked with passion. He knew that his creation had improved millions of lives. Women who thought their wrinkles were permanent found they could fade them. The dream he had carried through decades of quiet research had become real and lasting.
The Legacy
The Legacy
A peptide that changed how we think about aging skin
Key moment
Matrixyl is now used in over 500 commercial skincare products worldwide and remains the benchmark for cosmetic peptide efficacy
Today, over twenty years after its launch, Matrixyl remains one of the most studied and respected anti-wrinkle ingredients in skincare. It appears in hundreds of serums, creams, and masks sold worldwide. Scientists continue to research it, discovering new ways it helps skin. Some studies show it helps skin hold more water. Others show it protects against sun damage. The ingredient has inspired an entire category: cosmetic peptides. Companies now develop peptides for specific goals. Some target inflammation. Others help with skin tone. Some improve texture. None of this would exist without Matrixyl opening the door. Karl's work proved a powerful truth: tiny molecules can deliver big messages. Skin cells listen to the right messages. We do not have to accept wrinkles as inevitable. This philosophy changed the entire anti-aging skincare industry. Today, peptides are considered essential in serious skincare. Dermatologists recommend them. Beauty experts expect them. Consumers trust them. And it all traces back to one scientist who believed that a small peptide with the right passport—a fatty acid chain—could teach old skin to act young again.
Peptide history · 2000
Palmitoyl Pentapeptide-4
The wrinkle fighter that teaches old skin to act young again
Matrixyl is a tiny messenger that talks to your skin's deep layers. It tells cells to make more collagen, the stuff that keeps skin firm and smooth. Scientists launched it in 2000 as the first peptide with real proof of anti-wrinkle power.
Year Sederma introduced Matrixyl to the market
KTTKS linked to a palmitic acid chain
Measured in daltons, a way to count atomic weight
Average wrinkle depth reduction in 2 months
When this peptide was first identified
Compound classification
Dr. Karl Lintner
The Peptide Pioneer · Sederma SAS
Karl earned his PhD in biochemistry from Vienna University. He spent ten years studying peptides at France's Nuclear Research Center, publishing over 30 papers. In the late 1990s at Sederma, Karl led the team that designed Matrixyl by attaching a fatty acid to a five-amino-acid chain. This made the molecule stick to skin better. His work proved that this simple change could tell skin cells to make collagen like they were young again. In 2013, Paris gave him the Lifetime Achievement Award for his breakthrough.
I wanted to create a messenger that skin would actually listen to. The key was making it fat-loving so it could reach the deep layers where collagen lives.
Dr. Claire Mas-Chamberlin
The Validation Expert · Sederma SAS
Claire worked alongside Karl to test Matrixyl in real human skin. She designed experiments that measured how much collagen cells actually made when exposed to Matrixyl. Her clinical studies showed that after just two months, wrinkles got 45% shallower. This was the proof the world needed to believe that a tiny peptide could actually fight aging.
Numbers don't lie. When we measured the skin, wrinkles were measurably shallower. That made us believers.
Modern Research Teams
Clinical Validation & Commercialization · Multiple research institutions worldwide
Advancing clinical trials and bringing the peptide to therapeutic application
11 milestones, 1973 – 2023.
- 1973Karl Lintner begins ten-year research on biological peptides at France's Nuclear Research Center
- 1983Karl completes peptide research at Saclay and joins Henkel in Germany
- 1995Karl Lintner joins Sederma and begins designing anti-wrinkle peptides
- 1998First successful laboratory tests of Pal-KTTKS on human skin cells
- 2000Matrixyl launches commercially under Sederma's brand
- 2001First peer-reviewed clinical studies published showing 45% wrinkle reduction
- 2005Matrixyl becomes most requested anti-wrinkle peptide ingredient worldwide
- 2006Official naming change from Pentapeptide-3 to Pentapeptide-4
- 2010Sederma becomes part of Croda International
- 2013Karl Lintner receives Lifetime Achievement Award at in-cosmetics Paris
- 2023Matrixyl in over 500 skincare products globally with continued research
Your skin has a problem: it stops making new collagen after age 30. Collagen is the scaffold that keeps skin plump and smooth. Without new collagen, skin sags and wrinkles form. Matrixyl is like a messenger that reminds your skin cells they should keep working. It attaches to sensors on fibroblasts—the factory cells that make collagen. When Matrixyl locks onto these sensors, it sends a signal: start building collagen again. The fatty acid chain helps Matrixyl reach these deep cells. Without the fat chain, the peptide would just sit on the skin surface. With it, Matrixyl penetrates five to six times deeper than regular peptides.
Molecular structure
- Amino Acids
- 5 (KTTKS)
- Molecular Weight
- 802 Da
- Fatty Acid Attached
- Palmitic Acid (16 carbons)
- Peptide Type
- Matrikine
Average decrease in wrinkle measurement in clinical studies over 8-12 weeks
Number of commercial formulas worldwide that contain Matrixyl
Time since launch in 2000 with continuous research and development
Scientific papers documenting Matrixyl's effects by independent researchers
Real stories, real lives
Margaret
I had deep wrinkles around my mouth and eyes that made me look angry even when I was happy. After three months using a Matrixyl serum daily, my daughter asked what I was doing differently. My wrinkles were noticeably shallower. For the first time in years, I felt like my skin matched how young I felt inside.
Elena
I was about to get Botox because I thought that was my only choice. My dermatologist suggested trying Matrixyl first. After eight weeks, my forehead lines faded enough that I canceled the procedure. I get compliments on my skin now, and I love knowing it is just good skincare, not injections.
Sarah
Wrinkles were my biggest insecurity. Matrixyl gave me real, measurable results. Every week I looked slightly smoother. It was not instant, but it was real. That made me actually trust the product and stick with it.
The future of Palmitoyl Pentapeptide-4 (Matrixyl)
- Combination TherapiesIn Development
Research is testing Matrixyl combined with other peptides to address multiple aging signs at once
- Targeted DeliveryIn Development
Scientists are designing smarter ways to get Matrixyl exactly where it needs to go in the skin
- Sensitivity ImprovementsIn Development
New formulas aim to make Matrixyl work for sensitive skin types without irritation
- Injectable FormulasResearch Phase
Exploration of Matrixyl in micro-injection forms for enhanced skin thickness
Be inspired
The story of Palmitoyl Pentapeptide-4 (Matrixyl) is ultimately about the relentless pursuit of better medicine for humanity.
Continue the legacy. The next breakthrough could be yours.